Going High with Heart Disease: The Effect of High Altitude Exposure in Older Individuals and Patients with Coronary Artery Disease

被引:35
作者
Levine, Benjamin D. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Inst Exercise & Environm Med, Dallas, TX 75231 USA
关键词
aging; altitude; coronary artery disease; hypoxia; sudden cardiac death; SUDDEN CARDIAC DEATH; MYOCARDIAL BLOOD-FLOW; EXERCISE TOLERANCE; ATHEROSCLEROSIS; MECHANISMS; INFARCTION; RESPONSES; HYPOXIA; CALCIUM; HUMANS;
D O I
10.1089/ham.2015.0043
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Levine, Benjamin D. Going high with heart disease: The effect of high altitude exposure in older individuals and patients with coronary artery disease. High Alt Med Biol 16:89-96, 2015.Ischemic heart disease is the largest cause of death in older men and women in the western world (Lozano et al., 2012; Roth et al., 2015). Atherosclerosis progresses with age, and thus age is the dominant risk factor for coronary heart disease in any algorithm used to assess risk for cardiovascular events. Subclinical atherosclerosis also increases with age, providing the substrate for precipitation of acute coronary syndromes. Thus the risk of high altitude exposure in older individuals is linked closely with both subclinical and manifest coronary heart disease (CHD). There are several considerations associated with taking patients with CHD to high altitude: a) The reduced oxygen availability may cause or exacerbate symptoms; b) The hypoxia and other associated environmental conditions (exercise, dehydration, change in diet, thermal stress, emotional stress from personal danger or conflict) may precipitate acute coronary events; c) If an event occurs and the patient is far from advanced medical care, then the outcome of an acute coronary event may be poor; and d) Sudden death may occur. Physicians caring for older patients who want to sojourn to high altitude should keep in mind the following four key points: 1). Altitude may exacerbate ischemic heart disease because of both reduced O-2 delivery and paradoxical vasoconstriction; 2). Adverse events, including acute coronary syndromes and sudden cardiac death, are most common in older unfit men, within the first few days of altitude exposure; 3). Ensuring optimal fitness, allowing for sufficient acclimatization (at least 5 days), and optimizing medical therapy (especially statins and aspirin) are prudent recommendations that may reduce the risk of adverse events; 4). A graded exercise test at sea level is probably sufficient for most clinical decision making and will allow for assessment of exercise capacity, and provocable ischemia. Given these considerations, most older individuals with CHD should be able to tolerate exposure to high altitude safely, and with minimal increased risk.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条
[21]   Predictors of high-risk coronary artery disease detected by coronary computed tomographic angiography in diabetic patients without known coronary artery disease [J].
Iwasaki, Kohichiro ;
Matsumoto, Takeshi ;
Hasegawa, Kan .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 :324-325
[22]   Altitude and the heart: Is going high safe for your cardiac patient? [J].
Higgins, John P. ;
Tuttle, Troy ;
Higgins, Johanna A. .
AMERICAN HEART JOURNAL, 2010, 159 (01) :25-32
[23]   High plasma concentrations of vanin-1 in patients with coronary artery disease [J].
Yoshimi Kishimoto ;
Emi Saita ;
Reiko Ohmori ;
Kazuo Kondo ;
Yukihiko Momiyama .
Heart and Vessels, 2024, 39 :10-17
[24]   Impact of high altitude on echocardiographically determined cardiac morphology and function in patients with coronary artery disease and healthy controls [J].
de Vries, S. T. ;
Kleijn, S. A. ;
van't Hof, A. W. J. ;
Snaak, H. ;
van Enst, G. C. ;
Kamp, O. ;
Breeman, A. .
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2010, 11 (05) :446-450
[25]   Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease [J].
Gao, Jie ;
Lu, Jun ;
Sha, Wenjun ;
Xu, Bilin ;
Zhang, Cuiping ;
Wang, Hongping ;
Xia, Juan ;
Zhang, Hong ;
Tang, Wenjun ;
Lei, Tao .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[26]   Polyvascular Disease and the Incidence of Cancer in Patients with Coronary Artery Disease [J].
Suzuki, Makoto ;
Tomoike, Hitonobu ;
Dai, Zhehao ;
Hosoda, Toru ;
Sumiyoshi, Tetsuya ;
Hosoda, Saichi ;
Isobe, Mitsuaki .
JMA JOURNAL, 2022, 5 (04) :498-509
[27]   Effect of percutaneous coronary intervention on heart rate recovery in patients with coronary artery disease [J].
Liu, Jianguo ;
Xu, Aibin ;
Niu, Lili ;
Li, Junxia .
CORONARY ARTERY DISEASE, 2015, 26 (05) :442-447
[28]   Effect of Percutaneous Coronary Intervention on Heart Rate Variability in Coronary Artery Disease Patients [J].
Abdelnaby, Mahmoud H. .
EUROPEAN CARDIOLOGY REVIEW, 2018, 13 (01) :60-61
[29]   Coronary Artery Bypass Graft Effect on Cardiogoniometry Characteristic in Patients with Coronary Heart Disease [J].
Sadeghpourtabaei, Ali ;
Behjati, Mohaddeseh ;
Baharestani, Bahador ;
Tohidi, Fatemeh .
RESEARCH IN CARDIOVASCULAR MEDICINE, 2024, 13 (01) :10-13
[30]   High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment [J].
Couselo-Seijas, Marinela ;
Maria Agra-Bermejo, Rosa ;
Luis Fernandez, Angel ;
Manuel Martinez-Cereijo, Jose ;
Sierra, Juan ;
Soto-Perez, Maeve ;
Rozados-Luis, Adriana ;
Ramon Gonzalez-Juanatey, Jose ;
Eiras, Sonia .
ATHEROSCLEROSIS, 2020, 292 :60-69